TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 127 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 714,285 | $2,121,000 | 0.65% |
| Vivo Capital, LLC | 2,675,133 | $7,945,000 | 0.55% |
| Samsara BioCapital, LLC | 289,068 | $859,000 | 0.22% |
| Orbimed Advisors | 3,791,204 | $11,260,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,345,959 | $6,967,000 | 0.16% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,238,800 | $3,679,000 | 0.11% |
| Antara Capital LP | 1,074,834 | $3,192,000 | 0.10% |
| COWEN AND COMPANY, LLC | 85,000 | $252,000 | 0.02% |
| Marquette Asset Management, LLC | 21,802 | $65,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 85,851 | $255,000 | 0.01% |